Market News & Trends
EMD Millipore Introduces Kits for the Analysis of Chromatin-Associated RNAs
EMD Millipore recently introduced Magna ChIRP RNA Interactome Kits, which allow researchers to more easily identify, recover, and analyze regions of chromatin that interact with…
Vetter Serializes the First Product for South Korea
Vetter recently announced the manufacture of the first commercial batches with single-use identification numbers. Following the introduction of a comprehensive serialization service last year, the…
Exco InTouch Predicts Substantial Growth in Device Integration
Exco InTouch predicts a substantial increase in device integration in clinical trials and real-world programs in 2015 and beyond. Device integration has proved highly beneficial,…
Innate Pharma and AstraZeneca Announce Global Agreement
Innate Pharma SA recently announced that it has signed a co-development and commercialization agreement with AstraZeneca, along with MedImmune, its global biologics research and development…
Clover Oncology Receives Breakthrough Therapy Designation
Clovis Oncology, Inc. recently announced the US FDA has granted Breakthrough Therapy designation for the company’s investigational agent rucaparib as monotherapy treatment of advanced ovarian…
Celgene to Acquire Biotech Company
Celgene Corporation and Quanticel Pharmaceuticals, Inc. recently announced a definitive share purchase agreement under which Celgene Corporation will acquire Quanticel. Through the agreement, Celgene will…
CMOCRO: Intuitive Platform Provides Quick Access to Global Database of Pharmaceutical Suppliers, Supports Partnering Decisions
By: Ashish Shukla, PhD CMOCRO is an intuitive platform designed to quickly access a global database of pharmaceutical suppliers, and aims to support…
Huntingdon Life Sciences & Harlan Laboratories Announce Significant Launch
Huntingdon Life Sciences and Harlan Laboratories recently announced the launch of the SHrN – the world’s first hairless NOD.SCID mouse model to reach the market.…
Deciphera Pharmaceuticals Presents Data Highlighting Kinase Inhibitor Pipeline
Deciphera Pharmaceuticals recently announced that preclinical data on the company’s growing pipeline of next-generation kinase inhibitors were presented at the American Association for Cancer Research…
BIND Therapeutics Presents Positive Data Highlighting Ability of Accurins
BIND Therapeutics, Inc. recently announced that clinical and preclinical data from its oncology pipeline, including proprietary and collaboration programs, were presented at the American Association…
Ease the Path To Biosimilars Approval
Biosimilars Market Exploding! Do You Know FDA Requirements? Successful 351(k) Biosimilar Applications When it comes to FDA approval for biosimilars, the devil is in the…
EMA Endorses Development of Generic Topicals
European regulators are looking to industry for suggestions on the best ways to get generic versions of topical drugs approved without having to conduct time-consuming…
Generex Announces New $11-Million Collaboration
Generex Biotechnology Corporation recently announced that it has entered into a non-binding Letter of Intent (LOI) to license the Generex proprietary RapidMis drug delivery technologies…
Investigational Brain Cancer Vaccine Produces Strong Immunological Response
A first-of-its kind cancer vaccine, SurVaxM, has demonstrated safety and tolerability in patients with recurrent or progressive malignant brain tumors, according to results of a…
Dicerna Presents New Data From Multiple Tumor Models
Dicerna Pharmaceuticals, Inc. recently announced promising new in vivo data for CTNNB1 DsiRNA in multiple patient-derived xenograft (PDX) and other models of diverse tumor types.…
Gx MultiShell Unites the Properties of Glass & Plastic
Every day, millions of people are treated with parenteral medications, such as precautionary vaccinations or injections and infusions for medical conditions. Gerresheimer supplies the pharmaceutical…
Teva's Potential $40-Billion Acquisition Could Transform Generics Space
Teva Pharmaceutical Industries’ recent $40.1-billion offer to purchase Netherlands-based Mylan, which is crucially contingent on Mylan not consummating its offer to acquire Irish firm Perrigo,…
Pipeline Advancements & Asset Acquisitions Fueled Mid-Cap Biotech Research & Development Spend in 2014
The combined spend on research and development (R&D) for the peer group of 35 mid-cap biotech companies increased by nearly $2 billion to reach a…
New Jersey Pharmaceutical Association for Science & Technology Celebrates 60th Anniversary
The New Jersey Pharmaceutical Association for Science and Technology (NJPhAST) will be launching the celebration of its 60th anniversary at its September 17th meeting…
Q1 2015 Global Pharma, Medical & Biotech Trend Report
Mergermarket has released its Global Pharma, Medical & Biotech (PMB) trend report for the first quarter (Q1) of 2015. Take a look at the full…
